CN100574773C - The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease " - Google Patents

The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease " Download PDF

Info

Publication number
CN100574773C
CN100574773C CN200610043276A CN200610043276A CN100574773C CN 100574773 C CN100574773 C CN 100574773C CN 200610043276 A CN200610043276 A CN 200610043276A CN 200610043276 A CN200610043276 A CN 200610043276A CN 100574773 C CN100574773 C CN 100574773C
Authority
CN
China
Prior art keywords
medicine
ctenopharyngodon idellus
rot disease
endo
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200610043276A
Other languages
Chinese (zh)
Other versions
CN101045078A (en
Inventor
樊国平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200610043276A priority Critical patent/CN100574773C/en
Publication of CN101045078A publication Critical patent/CN101045078A/en
Application granted granted Critical
Publication of CN100574773C publication Critical patent/CN100574773C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses the endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease ", it is formulated by: Enrofloxacin HCL, trimethoprim, the Radix Astragali.The present invention can be by antimicrobial drug and synergist associating compatibility, to improve the antibacterial action and the prophylactic treatment effect of medicine, compatibility has the prevention of imitating and treats the generation of this disease, compatibility has the Chinese herbal medicine of immunization, purpose is the non-specific immunity that effectively strengthens Ctenopharyngodon idellus, to improve the result of use of medicine.Drug therapy Ctenopharyngodon idellus of the present invention " bacterial gill rot disease " cure rate can reach more than 80%.

Description

The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease "
Affiliated technical field
The present invention relates to fish disease prevention and cure medicine in a kind of aquaculture, especially treat the endo-medicine of Ctenopharyngodon idellus " bacterial gill rot disease ".
Background technology
Ctenopharyngodon idellus " bacterial gill rot disease " is the disease that is caused by bacterial infection.Though the aquatic science worker has done a large amount of scientific researches and production practices work to Ctenopharyngodon idellus " bacterial gill rot disease ", it is still the important diseases of present puzzlement Ctenopharyngodon idellus aquaculture.In the Ctenopharyngodon idellus breeding production, the sickness rate of Ctenopharyngodon idellus " bacterial gill rot disease " is the highest, dead quantity maximum, and cure rate is lower, and the culturing economic loss that causes thus is also bigger.Therefore, we had done a large amount of experiments and work to this in the last few years, had summed up the technological package measure of prevention and treatment Ctenopharyngodon idellus " bacterial gill rot disease ", and had optimized the specially good effect endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease ".Production practices in recent years prove that this endo-medicine reaches more than 90% the cure rate of Ctenopharyngodon idellus " bacterial gill rot disease ".
Summary of the invention
We selected for use the 3rd generation synthetic quinolone antimicrobial, synergist and Chinese herbal medicine with immunization carry out prescription, and be applied to the screening that breeding production is carried out endo-medicine, be intended to optimize best and endo-medicine specific prevention and treatment Ctenopharyngodon idellus " three diseases ".Composition principle: antimicrobial drug and synergist associating compatibility, with the antibacterial action that improves medicine and prevention, therapeutic effect: compatibility has the Chinese herbal medicine of immunization, its effect is the non-specific immunity that effectively strengthens Ctenopharyngodon idellus, improves its premunition, to promote the result of use of medicine.
The object of the present invention is achieved like this
By screening, the ingredient in prevention and treatment Ctenopharyngodon idellus " bacterial gill rot disease " the endo-medicine prescription has following three kinds:
1. Enrofloxacin HCL: its chemistry is by name: 1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-7-(4-ethyl-1-piperazinyl)-3-quinoline carboxylic acid, crystalline powder for little yellow and faint yellow, odorless, mildly bitter flavor, belong to synthetic quinolones broad spectrum antibiotic of the 3rd generation, the DNA gyrase that can effectively suppress antibacterial, blocking-up duplicating of DNA of bacteria and produce the quick sterilization effect.Therefore, Gram-positive, negative bacterium and each mycoplasma species etc. all there are very strong killing action, splendid to the curative effect of mycoplasma and various bacteria mixed infection.And its sterilizing power is strong, absorbs soon, and it is wide to distribute, and untoward reaction is few, and does not have cross resistance between other antimicrobial agents, not influenced by plasmid conduction drug resistance.
2, trimethoprim: have another name called trimethoxy diamino, trimethoprim (TMP), trimethoprim, its chemistry is by name: 2,4 diaminourea-5-(3,4,5-trimethoxy benzyl) pyrimidine is white or off-white color crystalline powder.Its antimicrobial spectrum is similar substantially with sulphonamides, but antibacterial action is stronger, and its basic antibacterial action mechanism is to suppress the antibacterial dihydrofolate reductase, thereby stops the synthetic of bacterial nucleic acid.Use separately, the very easy generation drug resistance of antibacterial, effective to multiple Grain-positive and negative bacteria.But during with the sulphonamides use in conjunction, can make the folic acid metabolism of antibacterial suffer double blocking, the antibacterial action that strengthens sulfanilamide reaches several times to tens times, experiment showed, that TMP and Enrofloxacin HCL compatibility use, and its antibacterial action and curative effect all obviously strengthen.
3, the Radix Astragali: have another name called hundred, hundred absorbent cotton etc., it is a kind of Chinese herbal medicine, its powder is a yellow-white, it not only has the promotion organism metabolism, antibiotic and suppress virus, enhanced virus inducement interferon, body hypoxia-bearing and stress ability, improve cardiac function, blood sugar regulation, blood pressure lowering, effect such as protect the liver, and can strengthen the fish body immunity function, improve premunition, promptly, blood leukocytes and multinuclear leucocyte quantity are significantly increased by strengthening the phagocytic function of reticuloendothelial system, macrophage phagocytic percentage rate index significantly rises, thereby humoral immunization is all had facilitation.
Prescription is formed: the former powder 30-50 of Enrofloxacin HCL milligram, the former powder 6-10 of trimethoprim milligram, astragalus membranaceus powder 1.5-2 kilogram, other adds flour 2.5-3 kilogram.
Using method;
Said medicine is added in the double centner feed of grass carp, threw something and fed continuously 5-7 days, use and treat Ctenopharyngodon idellus " bacterial gill rot disease ", during prevention, the addition of medicine reduces by half.Simultaneously even water disinfectant such as float chlorine dioxide in the breeding water body to improve water quality, is beneficial to the prevention and the treatment of Ctenopharyngodon idellus " bacterial gill rot disease ".

Claims (1)

1. the endo-medicine of a therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease ", it is characterized in that forming by the following weight ratio component, the former powder 30-50 of Enrofloxacin HCL milligram, the former powder 6-10 of trimethoprim milligram, astragalus membranaceus powder 1.5-2 kilogram, other adds flour 2.5-3 kilogram, above-mentioned component is gone packing again after mixing.
CN200610043276A 2006-03-27 2006-03-27 The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease " Expired - Fee Related CN100574773C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200610043276A CN100574773C (en) 2006-03-27 2006-03-27 The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease "

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200610043276A CN100574773C (en) 2006-03-27 2006-03-27 The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease "

Publications (2)

Publication Number Publication Date
CN101045078A CN101045078A (en) 2007-10-03
CN100574773C true CN100574773C (en) 2009-12-30

Family

ID=38770180

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200610043276A Expired - Fee Related CN100574773C (en) 2006-03-27 2006-03-27 The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease "

Country Status (1)

Country Link
CN (1) CN100574773C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102144967B (en) * 2010-04-23 2012-06-06 镇江威特药业有限责任公司 Veterinary long-acting compound doxycycline injection and preparation method thereof
CN103251753B (en) * 2013-06-08 2014-07-02 潘李亮 Traditional Chinese medicine composition for treating streptococcicosis of tilapia mossambica
CN104800162A (en) * 2014-01-26 2015-07-29 天津嘉创生物科技有限公司 Splashing medicinal composition for treating fish branchiomycosis, and preparation method thereof
CN105327319A (en) * 2015-11-27 2016-02-17 青岛海之源智能技术有限公司 Tincture for treating bacterial gill-rot disease of channel catfish and preparation method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
32种抗菌药物对临床分离猪源链球菌的体外抗菌活性. 王丽平,陆承平,唐家琪.微生物学报,第44卷第6期. 2004
32种抗菌药物对临床分离猪源链球菌的体外抗菌活性. 王丽平,陆承平,唐家琪.微生物学报,第44卷第6期. 2004 *
月桂氮卓酮和月桂酸对利多卡因经皮渗透的促进作用. 邱瑜等.上海第二医科大学学报,第18卷第4期. 1998
月桂氮卓酮和月桂酸对利多卡因经皮渗透的促进作用. 邱瑜等.上海第二医科大学学报,第18卷第4期. 1998 *
耐药性伤寒药物治疗概况. 马丽,张继兰,曹培真.医药导报,第14卷第6期. 1995
耐药性伤寒药物治疗概况. 马丽,张继兰,曹培真.医药导报,第14卷第6期. 1995 *

Also Published As

Publication number Publication date
CN101045078A (en) 2007-10-03

Similar Documents

Publication Publication Date Title
CN100574773C (en) The endo-medicine of a kind of therapy of combining Chinese and Western medicine Ctenopharyngodon idellus " bacterial gill rot disease "
CN103142908A (en) Spray for killing mites on body surface of pet and preparation method of spray
WO2005044287A1 (en) Disinfecting composition and methods of making and using same
CN106309401A (en) Bathing effervescent tablets for preventing and treating skin diseases
CN101985050A (en) Hygienic product
CN106938046A (en) A kind of antibacterial peptide complex enzyme oral spray
CN101829124B (en) Veterinary compound sulfadiazine sodium injection and preparation method thereof
CN113995744A (en) Composition and antibacterial application thereof
CN101474284A (en) External use medicament for treating fungal dermatopathy
CN107951961A (en) A kind of Chinese-herb disinfectant for prawn culturing
CN104800229B (en) A kind of compound sulfadiazine suspension and preparation method thereof
CN110448554A (en) Application of D-penicillamine and fluconazole in preparation of antifungal product
CN105998323A (en) Film-forming pharmaceutical composition for preventing and treating cow mastitis as well as application and preparation method of pharmaceutical composition
CN101829129B (en) Veterinary compound gentamycin sulfate injection and preparation method thereof
CN108837025A (en) A kind of Chinese medicine pre-mixing agent and preparation method thereof for preventing and treating diarrhea of weaned piglets
CN101468025A (en) Soluble powder for preventing and treating colibacillosis of fowl
CN1947756A (en) Formula of seven herbs medicine composition for relieving internal heat and invigorating blood circulation, its prepn. process and use
CN110402929A (en) A kind of bactericidal composition and its application containing jinggangmeisu
CN105228594A (en) Be used for the treatment of powder composition and the application thereof of mammal auditory meatus disease
CN109288796A (en) Composite sulfamonomethoxine soluble powder of sodium
CN103719167A (en) Degerming agent specially used for aeromonas hydrophila water body
CN1190190C (en) Antiviral and antibacterial cantharidinic anhydride medicine composition and its prepn process
JPH07101810A (en) Sterilizing composition and soap containing said composition
CN101766650B (en) Washing liquor for operation and method for preparing same
CN102697677A (en) Dedicated plant disinfection hand sanitizer for medical staff

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091230

Termination date: 20100327